Distinguishing malignant from benign microscopic skin lesions using desorption electrospray ionization mass spectrometry imaging

Significance Timely detection of microscopic tumors is of utmost importance in cancer diagnostics. We show that desorption electrospray ionization mass spectrometry imaging (DESI-MSI) can successfully locate microscopic aggregates of a common skin cancer, basal cell carcinoma (BCC), and distinguish them from adjacent normal skin. DESI-MSI unveils an altered chemical profile in BCC region, including lipids and metabolites, and does not rely on visual identification of histopathologic features. We processed specimens from 86 Mohs micrographic surgeries, with nearly 60% of tumors sized less than 1 mm in diameter. By applying the statistical method of least absolute shrinkage and selection operator (Lasso) on collected DESI-MSI data, we were able to achieve up to 94.1% diagnostic accuracy compared with pathological evaluation of BCC. Detection of microscopic skin lesions presents a considerable challenge in diagnosing early-stage malignancies as well as in residual tumor interrogation after surgical intervention. In this study, we established the capability of desorption electrospray ionization mass spectrometry imaging (DESI-MSI) to distinguish between micrometer-sized tumor aggregates of basal cell carcinoma (BCC), a common skin cancer, and normal human skin. We analyzed 86 human specimens collected during Mohs micrographic surgery for BCC to cross-examine spatial distributions of numerous lipids and metabolites in BCC aggregates versus adjacent skin. Statistical analysis using the least absolute shrinkage and selection operation (Lasso) was employed to categorize each 200-µm-diameter picture element (pixel) of investigated skin tissue map as BCC or normal. Lasso identified 24 molecular ion signals, which are significant for pixel classification. These ion signals included lipids observed at m/z 200–1,200 and Krebs cycle metabolites observed at m/z < 200. Based on these features, Lasso yielded an overall 94.1% diagnostic accuracy pixel by pixel of the skin map compared with histopathological evaluation. We suggest that DESI-MSI/Lasso analysis can be employed as a complementary technique for delineation of microscopic skin tumors.

[1]  Trevor Hastie,et al.  An Introduction to Statistical Learning , 2013, Springer Texts in Statistics.

[2]  D. Muddiman,et al.  Characterization of the Spectral Accuracy of an Orbitrap Mass Analyzer Using Isotope Ratio Mass Spectrometry. , 2018, Analytical chemistry.

[3]  A. Jarmusch,et al.  Intraoperative assessment of tumor margins during glioma resection by desorption electrospray ionization-mass spectrometry , 2017, Proceedings of the National Academy of Sciences.

[4]  Richard E. Fan,et al.  Diagnosis of prostate cancer by desorption electrospray ionization mass spectrometric imaging of small metabolites and lipids , 2017, Proceedings of the National Academy of Sciences.

[5]  R. Schwartz,et al.  Cost effectiveness of Mohs micrographic surgery for non-melanoma skin cancer: a systematic review protocol , 2017 .

[6]  R. Dellavalle,et al.  Effectiveness of Mohs micrographic surgery for nonmelanoma skin cancer: a systematic review protocol. , 2017, JBI database of systematic reviews and implementation reports.

[7]  T. Lotti,et al.  Histopathologic pitfalls of Mohs micrographic surgery and a review of tumor histology , 2018, Wiener Medizinische Wochenschrift.

[8]  R. Tibshirani,et al.  Cardiolipins Are Biomarkers of Mitochondria-Rich Thyroid Oncocytic Tumors. , 2016, Cancer research.

[9]  A. Zarrine-Afsar,et al.  Rapid Detection of Necrosis in Breast Cancer with Desorption Electrospray Ionization Mass Spectrometry , 2016, Scientific Reports.

[10]  R. Tibshirani,et al.  Pancreatic Cancer Surgical Resection Margins: Molecular Assessment by Mass Spectrometry Imaging , 2016, PLoS medicine.

[11]  A. Jarmusch,et al.  Lipid and metabolite profiles of human brain tumors by desorption electrospray ionization-MS , 2016, Proceedings of the National Academy of Sciences.

[12]  S. Seneff,et al.  A novel hypothesis for atherosclerosis as a cholesterol sulfate deficiency syndrome , 2015, Theoretical Biology and Medical Modelling.

[13]  R. Zare,et al.  MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism , 2015, Proceedings of the National Academy of Sciences.

[14]  Isaiah Norton,et al.  Application of desorption electrospray ionization mass spectrometry imaging in breast cancer margin analysis , 2014, Proceedings of the National Academy of Sciences.

[15]  G. Shui,et al.  CDP-Diacylglycerol Synthetase Coordinates Cell Growth and Fat Storage through Phosphatidylinositol Metabolism and the Insulin Pathway , 2014, PLoS genetics.

[16]  R. Tibshirani,et al.  Molecular assessment of surgical-resection margins of gastric cancer by mass-spectrometric imaging , 2014, Proceedings of the National Academy of Sciences.

[17]  F. Jolesz,et al.  Mass spectrometry imaging as a tool for surgical decision-making. , 2013, Journal of mass spectrometry : JMS.

[18]  A. Schulze,et al.  Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development , 2013, Disease Models & Mechanisms.

[19]  Daniela M. Witten,et al.  An Introduction to Statistical Learning: with Applications in R , 2013 .

[20]  David C Muddiman,et al.  MSiReader: An Open-Source Interface to View and Analyze High Resolving Power MS Imaging Files on Matlab Platform , 2013, Journal of The American Society for Mass Spectrometry.

[21]  Josephine Bunch,et al.  Inclusive sharing of mass spectrometry imaging data requires a converter for all. , 2012, Journal of proteomics.

[22]  M. Sporn,et al.  NRF2 and cancer: the good, the bad and the importance of context , 2012, Nature Reviews Cancer.

[23]  R. Cooks,et al.  Improved spatial resolution in the imaging of biological tissue using desorption electrospray ionization , 2012, Analytical and Bioanalytical Chemistry.

[24]  J. Fargnoli,et al.  Cancer Cell Dependence on Unsaturated Fatty Acids Implicates Stearoyl-CoA Desaturase as a Target for Cancer Therapy , 2011, Molecular Cancer Research.

[25]  R. Heeren,et al.  A concise review of mass spectrometry imaging. , 2010, Journal of chromatography. A.

[26]  R. Deberardinis Is cancer a disease of abnormal cellular metabolism? New angles on an old idea , 2008, Genetics in Medicine.

[27]  Robert Burke,et al.  ProteoWizard: open source software for rapid proteomics tools development , 2008, Bioinform..

[28]  R. Cooks,et al.  Mass Spectrometry Sampling Under Ambient Conditions with Desorption Electrospray Ionization , 2004, Science.

[29]  Yuko Higashi,et al.  Cholesterol sulfate in human physiology: what's it all about? , 2003, Journal of lipid research.

[30]  R. Tibshirani The lasso method for variable selection in the Cox model. , 1997, Statistics in medicine.

[31]  T. Kuroki,et al.  Cholesterol sulfate, a second messenger for the eta isoform of protein kinase C, inhibits promotional phase in mouse skin carcinogenesis. , 1995, Cancer research.

[32]  M. Rustin,et al.  Arachidonic acid metabolites in cutaneous carcinomas. , 1987, Archives of dermatology.

[33]  N. Swanson,et al.  Arachidonic acid metabolites in cutaneous carcinomas. Evidence suggesting that elevated levels of prostaglandins in basal cell carcinomas are associated with an aggressive growth pattern. , 1986, Archives of dermatology.

[34]  P. Elias,et al.  Stratum corneum lipids in disorders of cornification. Steroid sulfatase and cholesterol sulfate in normal desquamation and the pathogenesis of recessive X-linked ichthyosis. , 1984, The Journal of clinical investigation.

[35]  P. Elias,et al.  The epidermal cholesterol sulfate cycle. , 1984, Journal of the American Academy of Dermatology.

[36]  A. Shug,et al.  Fatty Acid and Carnitine-Linked Abnormalities During Ischemia and Cardiomyopathy , 1983 .